Upregulation of Angiotensin II-AT1 Receptors During Statin Withdrawal in Vascular Smooth Muscle Cells
Authors:
- 1 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 50 (6) , 708-711
Abstract
Acute discontinuation of statins induces vascular dysfunction and increases cardiovascular events. The mechanisms underlying these events are under investigation. We showed an increase in angiotensin II (AngII) signaling after acute statin withdrawal. We investigated whether AngII-AT1-receptor expression (AT1-R mRNA) and receptor protein (AT1-R) levels mediate increased AngII signaling. In rat aortic vascular smooth muscle cells (VSMC), simvastatin (0.3 to 3 μM for 24 hours) resulted in concentration-dependent inhibition of AngII-stimulated phosphorylation of extracellular-signal regulated kinase 1/2 ERK1/2 (-67 ± 5% with 3 μM; P < 0.001) and decreased AT1-R mRNA (-34 ± 8% with 3 μM; P < 0.01) and AT1-R protein (-32 ± 6% with 3 μM; P < 0.01). Removal of simvastatin led to a rebound increase in mRNA-AT1-R (+39 ± 2%, P < 0.01), AT1-R protein (+46 ± 2%; P < 0.01), and AngII-mediated phosphorylation of ERK1/2 (+36 ± 3%; P < 0.01). The increase in receptor expression was present at 1 hour and lasted for 4 hours, whereas increased AT1-R protein and AngII signaling started at 2 hours and lasted for nearly 2 hours. In summary, increased AngII signaling after statin withdrawal is most likely due to increases in AT1-R number due to increased transcription. The increase in AngII activity may contribute to the vascular dysfunction associated with statin withdrawal.Keywords
This publication has 31 references indexed in Scilit:
- Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyCirculation, 2004
- Beneficial Cardiovascular Pleiotropic Effects of StatinsCirculation, 2004
- The power of statins: Aggressive lipid loweringClinical Cardiology, 2003
- Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cellsExperimental & Molecular Medicine, 2002
- Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart diseaseThrombosis Research, 2002
- Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthaseProceedings of the National Academy of Sciences, 1998
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- Statins do more than just lower cholesterolThe Lancet, 1996